Ruboxistaurin Completed Phase 3 Trials for Diabetic Retinopathy (DR) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00604383Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
NCT00266695Treatment for Completers of the Study B7A-MC-MBCM
NCT00090519Reduction in the Occurrence of Center-Involved Diabetic Macular Edema